MedTrace Logo

Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea

NCT02362711 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 248

Last updated 2019-04-16

No results posted yet for this study

Summary

The purpose of this long-term study is to determine whether NPC-16 is effective in the treatment of dysmenorrhea.

Conditions

  • Dysmenorrhea

Interventions

DRUG

NPC-16 Standard Dosing Regimen Group

DRUG

NPC-16 Continuous Dosing Regimen Group

DRUG

Placebo Group

Sponsors & Collaborators

  • Nobelpharma

    lead INDUSTRY

Principal Investigators

  • Tasuku Harada, MD, PhD · Tottori University

  • Mikio Momoeda, MD, PhD · St. Luke's International Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-01-31
Completion
2017-01-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02362711 on ClinicalTrials.gov